SCHEMBL4301028

SCHEMBL4301028

CC(C)CNC(=O)C(=O)N(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
KMT2A Q03164 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MMP1 P03956 1/20 0.43
MMP8 P22894 1/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
KDM4E B2RXH2 2/20 0.41
POLB P06746 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
TAS1R2 Q8TE23 1/20 0.40
EPHX1 P07099 2/20 0.37
HSD17B10 Q99714 2/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14080607 0.82 CYP2D6 (0.42) CYP2D6CYP2C19KMT2ANPC1RAB9A
SCHEMBL6850946 0.80 CYP2D6 (0.65) CYP2D6CYP2C19KMT2ANPC1RAB9A
SCHEMBL137568 0.76 CYP2D6 (0.54) CYP2D6CYP2C19KMT2ANPC1RAB9A
Hydrochloric Acid SCHEMBL3116027 0.75 CYP2D6 (0.43) CYP2D6CYP2C19KMT2ANPC1RAB9A
SCHEMBL4292891 0.73 MMP1 (0.37) KMT2AMMP1MMP8ALDH1A1POLB
SCHEMBL13589522 0.73 CYP2D6 (0.56) CYP2D6CYP2C19KMT2ANPC1RAB9A
SCHEMBL10432669 0.73 CYP2C19 (0.64) CYP2D6CYP2C19KMT2ANPC1RAB9A
SCHEMBL13588782 0.71 CYP2D6 (0.54) CYP2D6CYP2C19KMT2ANPC1RAB9A
SCHEMBL5001767 0.71 CYP2D6 (0.54) CYP2D6CYP2C19KMT2ANPC1RAB9A
Potassium Ion SCHEMBL6327133 0.71 CYP2D6 (0.54) CYP2D6CYP2C19KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221571-A1 HIV INTEGRASE INHIBITORS MSD ITALIA S.R.L. (IT) 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221571-A1 HIV INTEGRASE INHIBITORS TYMP, CDK2, TYMS CYP2D6 762/4885CYP2C19 315/4885KMT2A 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.